Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Liver Int. 2020 Mar 11;40(5):1111–1120. doi: 10.1111/liv.14417

Table 2:

PAI-1 levels by NAFLD* status

NAFLD 2010–11 (n=138) No NAFLD 2010–11 (n=671) P value+
1st Assessment PAI-1 level (1992–93) (ng/mL)
23.4 (13.9, 36.5) 11.9 (7.2, 19.8) <0.0001
2nd Assessment PAI-1 level (2005–06) (ng/mL)
55.6 (32.4, 87.1) 19.5 (12.5, 37.2) <0.0001
Change in PAI-1
28.7 (5.7, 62.4) 6.9 (0.5, 19.2) <0.0001

Data expressed as median (IQR)

Abbrevations: PAI-1, plasminogen activator inhibitor 1; NAFLD, non-alcoholic fatty liver disease; IQR, interquartile range.

*

NAFLD defined as LA≤51 HU on CT in the absence of secondary causes of steatosis

+

kruskal-Wallis test